Anticoagulation for left ventricular thrombi secondary to COVID—Is 3 months too long?
Abstract The length of anticoagulation for thrombotic events related to COVID‐19 is unknown. We present a patient with COVID‐19 complicated by a thrombotic anterior STEMI and multiple left ventricular (LV) thrombi that resolved after 8 weeks of anticoagulation. We suggest a shorter length of anticoa...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-06-01
|
| Series: | Clinical Case Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ccr3.5950 |